Esker Therapeutics Funding: $70M Raised, Series A (2021)
Esker Therapeutics is based in San Francisco, CA. It has raised $70M in total funding. Latest round: Series A. Backed by Foresite Capital.
Esker Therapeutics funding overview
Esker Therapeutics is based in San Francisco, CA. Esker Therapeutics has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2021. The round record for Esker Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Foresite Capital.
Esker Therapeutics at a glance
Total raised
$70M
Latest round
Series A
Latest round date
May 2021
Headquarters
San Francisco, CA
Notable investors
Foresite Capital
Frequently asked about Esker Therapeutics funding
How much has Esker Therapeutics raised?
Esker Therapeutics has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Esker Therapeutics?
Foresite Capital are named among the investors backing Esker Therapeutics.
What was the latest Esker Therapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2021.
Where is Esker Therapeutics based?
Esker Therapeutics is based in San Francisco, CA.
When did Esker Therapeutics last raise?
The last disclosed Esker Therapeutics round closed in May 2021 at Series A.
Totals shown for Esker Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.
